Market Overview:
The global gastrointestinal stents market size reached US$
409.0 Million in 2022. Looking forward, IMARC Group expects the market to reach US$
508.6 Million by 2028, exhibiting a growth rate (CAGR) of
3.5% during 2023-2028.
A gastrointestinal stent refers to an artificial tube graft that is inserted in the body to prevent blockages in the gullet, stomach and small intestine. It is an expandable metal or a plastic mesh tube that is placed in an anatomical duct, such as bile ducts, esophagus, bowel or colon, and blockages due to cancerous tissues. It aims to remove the obstruction and reduce the pressure caused by inflammation. Some of the most common types of gastrointestinal stents include biliary, colonic, duodenal, esophageal and pancreatic stents.
www.imarcgroup.com
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
To get more information on the regional analysis of this market, Request Sample
The rising prevalence of colorectal cancer across the globe is one of the key factors driving the growth of the market. Furthermore, an increasing geriatric population suffering from gastrointestinal diseases, such as bowel ailments, diverticulosis and gastrointestinal malignancies, is also providing a boost to the market growth. Additionally, the growing preference for minimally invasive (MI) surgical procedures, along with the rising health consciousness among the masses, is creating a significant impact on the market. In comparison to the traditional open surgery procedures, gastrointestinal stenting involves low risk of infections, minimal loss of blood and quick recuperation period. Moreover, various technological advancements, including the development of bio-absorbable and nitinol material-based stents offering a high degree of flexibility and kink-resistance, is acting as another growth-inducing factor. Other factors, including significant growth in the healthcare infrastructure, the implementation of favourable government policies and extensive research and development (R&D) activities, are projected to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global gastrointestinal stents market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, technology type, material and end user.
Breakup by Product Type:
www.imarcgroup.com
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
- Biliary Stents
- Duodenal Stents
- Colonic Stents
- Pancreatic Stents
- Esophageal Stents
Breakup by Technology Type:
- Anti-Migratory Stents
- Drug-Eluting Stents
- Radioactive Stents
- Anti-Reflux Stents
- Shape-Modified Stents
- Others
Breakup by Material:
- Plastic Stents
- Self-Expanding Metal Stents
- Stainless Steel Stents
- Nitinol Stents
- Others
- Covered Self-Expandable Metallic Stents
- Biodegradable or Drug Eluting Stents
Breakup by End User:
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centres
- Others
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Becton, Dickinson and Company, Boston Scientific Corporation, Cantel Medical Corporation, Conmed Corporation, Cook Group Incorporated, ELLA-CS, S.R.O., Hobbs Medical Inc., Merit Medical Systems Inc., Olympus Corporation, Taewoong Medical Co. Ltd., etc.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2022 |
Historical Period |
2017-2022 |
Forecast Period |
2023-2028 |
Units |
US$ Million |
Segment Coverage |
Product Type, Technology Type, Material, End User, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Becton, Dickinson and Company, Boston Scientific Corporation, Cantel Medical Corporation, Conmed Corporation, Cook Group Incorporated, ELLA-CS, S.R.O., Hobbs Medical Inc., Merit Medical Systems Inc., Olympus Corporation, Taewoong Medical Co. Ltd. |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |